Skip to content
★ Sign in to follow
Jinhai Medical Technology Ltd. logo

Jinhai Medical Technology Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$22.8BIndustrials

No insider purchase over the last 90 days. The latest, by Wang Zhenfei, was filed 10 Jan 2024.

Jinhai Medical Technology Ltd.: what insiders have been doing

Every trade that managers of Jinhai Medical Technology Ltd. disclose to HKEX is tracked on this page. The company sits in the Industrials sector. In the past year (9 November 2025 to 9 November 2026), 12 filings came from 5 insiders.

There is no open-market purchase to report; the filings show 10 sales worth €300.5M by 4 insiders. The amount is not disclosed for 9 filings. At €300.5M, the sale published on 9 November 2026 by Chen Guobao is the largest of the period.

Across the 1,323 companies tracked on its exchange, the median is 4 filings; at 12 filings, this issuer sits above that mark. Since 2018, the database holds 1 purchase and 12 sales by insiders of the company.

Filings reach the HKEX feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.

Elsewhere in the same sector, our signals recently picked up insider purchases at MBB SE and Kongsberg Maritime ASA. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.

Insider Decl.
16
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
€355M
12 ops. · all time

Who traded when

BuySale
Chen Guobao4 sales
Li Bin3 sales
Wang Zhenfei3 sales

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 23,814 of 26,913 companies
23.3
score / 100
Value
35
Quality
12
FCF yld-0.0%
Earn yld-0.1%
EV/EBITDA·
ROE-24%
Gross mgn16%
Net mgn-37%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$4.31
Analyst consensus
·
Income statement
RevenueHK$46.3M
Gross profitHK$7.2M16% margin
EBITDA-HK$11.9M-26% margin
Net income-HK$17.1M-17.0% margin
Valuation
P/Book70.1x
Beta0.39
Balance sheet & cash
Market capHK$22.8B
Total debtHK$14.9M
Free Cash Flow-HK$5.7M
Debt / Equity26%
Profitability & ownership
ROE-24.5%
ROA-9.1%
% insiders48.3%
% institutions0.1%
Last declaration on 9 November 2026
Declarations16 total
  • ▼
    DirectorExecutives
    3B HKD0HKEX
    1,057,486,000 shares@ HK$2.50ShareXHKGHKEX:DA20261109E00094
  • ▼
    DirectorExecutives
    0HKEX
    2,530,000,000 sharesShareXHKGHKEX:DA20261028E00054
  • ▼
    DirectorExecutives
    0HKEX
    40,000,000 sharesShareXHKGHKEX:DA20261028E00058
  • ▼
    DirectorExecutives
    0HKEX
    25,850,000 sharesShareXHKGHKEX:DA20261028E00060
  • ▼
    DirectorExecutives
    0HKEX
    2,530,000,000 sharesShareXHKGHKEX:DA20260916E00105
  • ▼
    DirectorExecutives
    0HKEX
    40,000,000 sharesShareXHKGHKEX:DA20260916E00173
  • ▼
    DirectorExecutives
    0HKEX
    25,850,000 sharesShareXHKGHKEX:DA20260916E00108
  • ▼
    DirectorExecutives
    0HKEX
    2,530,000,000 sharesShareXHKGHKEX:DA20260518E00042
  • ▼
    DirectorExecutives
    0HKEX
    40,000,000 sharesShareXHKGHKEX:DA20260518E00051
  • ▼
    DirectorExecutives
    0HKEX
    25,850,000 sharesShareXHKGHKEX:DA20260518E00045
  • ●
    DirectorExecutives
    0HKEX
    40,000,000 sharesShareXHKGHKEX:DA20260204E00211
  • ●
    DirectorExecutives
    0HKEX
    25,850,000 sharesShareXHKGHKEX:DA20260202E00027
  • ▲
    DirectorExecutives
    0HKEX
    6,462,500 sharesShareXHKGHKEX:DA20240110E00280
    Canonical exit: 8 Apr 2024 (T+90)
  • ●
    DirectorExecutives
    257M HKD19HKEX
    632,500,000 shares@ HK$0.4065100.0% of flowShareXHKGHKEX:DA20190722E00253
  • ▼
    DirectorExecutives
    257M HKD16HKEX
    632,500,000 shares@ HK$0.406553.2% of flowShareXHKGHKEX:DA20190529E00290
  • ▼
    DirectorExecutives
    241M HKD16HKEX
    290,000,000 shares@ HK$0.8346.8% of flowShareXHKGHKEX:DA20180516E00121

16 of 16 declarations

About Jinhai Medical Technology Ltd.

Jinhai Medical Technology Ltd. is a company focused on the development and manufacturing of innovative medical devices. It aims to enhance healthcare through advanced technologies.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations